Current Pharmaceutical Design
Title: Preface
Volume: 6 Issue: 6
Author(s): Zhou Xing
Affiliation:
Export Options
About this article
Cite this article as:
Xing Zhou, Preface, Current Pharmaceutical Design 2000; 6 (6) . https://dx.doi.org/10.2174/1381612003400579
DOI https://dx.doi.org/10.2174/1381612003400579 |
Print ISSN 1381-6128 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-4286 |
11
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Repurposing of Anti-Diabetic Agents for the Treatment of Cognitive Impairment and Mood Disorders
Current Molecular Medicine The Toxicology of Chemokine Inhibition
Mini-Reviews in Medicinal Chemistry Potential of Lung Surfactant Proteins, SP-A and SP-D, and Mannan Binding Lectin for Therapy and Genetic Predisposition to Allergic and Invasive Aspergillosis
Recent Patents on Inflammation & Allergy Drug Discovery The Chronic Painful Tendon-Vasculo/Neural Ingrowth the Target for Therapy
Drug Design Reviews - Online (Discontinued) Editorial (Hot Topics: Cardiovascular Dysfunction in Sepsis: From Basic Mechanisms to Clinical Management)
Current Vascular Pharmacology Immunopharmacological Activity of Betulin in Inflammation-associated Carcinogenesis
Anti-Cancer Agents in Medicinal Chemistry Patent Selections:
Recent Patents on Anti-Infective Drug Discovery Pharmacokinetics of Topical Ocular Drug Delivery: Potential Uses for the Treatment of Diseases of the Posterior Segment and Beyond
Current Drug Metabolism Gene-Nutrient Interaction in Type 2 Diabetes: An Appraisal of the Role of the Peroxisome Proliferator-Activated Receptor Pathway
Current Pharmacogenomics Impact of the CD40-CD40L Dyad in Alzheimers Disease
CNS & Neurological Disorders - Drug Targets Toll-Like Receptors and their Role in Hematologic Malignancies
Current Molecular Medicine A Potential Therapeutic Target RNA-binding Protein, Arid5a for the Treatment of Inflammatory Disease Associated with Aberrant Cytokine Expression
Current Pharmaceutical Design Statins and Alkylphospholipids as New Anticancer Agents Targeting Lipid Metabolism
Anti-Cancer Agents in Medicinal Chemistry Yoga may Prevent Cytokine Storm in COVID-19
Coronaviruses Visceral Adipose Tissue and Atherosclerosis
Current Vascular Pharmacology 5-Lipoxygenase: Cellular Biology and Molecular Pharmacology
Current Drug Targets - Inflammation & Allergy Nab-Paclitaxel in Metastatic Breast Cancer: Defining the Best Patient Profile
Current Cancer Drug Targets A Case for Innate Immune Effector Mechanisms as Contributors to Disease Resistance in SIV-Infected Sooty Mangabeys
Current HIV Research Pharmacology of Cyclic Peptides: Vancomycin and Oxytocin as Paradigms
Protein & Peptide Letters Pomegranate Consumption and Blood Pressure: A Review
Current Pharmaceutical Design